Clinical Trials Logo

Filter by:
NCT ID: NCT02468323 Completed - PONV Clinical Trials

Prophylactic Antiemetic Efficacy of Palonosetron Versus Ondansetron for Cesarean Sections Under Regional Anesthesia

PONV
Start date: October 2015
Phase: Phase 4
Study type: Interventional

This study aims to compare the quality of perioperative antiemesis of palonosetron and ondansetron in patients undergoing cesarean section

NCT ID: NCT02467972 Completed - Diabetes Clinical Trials

Functional Ingredients: Effect in Gastrointestinal System

Start date: April 2012
Phase: N/A
Study type: Interventional

The addition of fructans or unripe banana flour to frozen meals can change the hormonal parameters related to hunger and satiety, improve the bowel movements and increase in colonic bacteria population measured by microbiological determinations (qPCR). The inulin no can change bowel movements and increase in colonic bacteria population measured by microbiological determinations (qPCR)

NCT ID: NCT02467907 Completed - Cervical Cancer Clinical Trials

Safety and Efficacy of Bevacizumab in Combination With Carboplatin and Paclitaxel for Metastatic, Recurrent or Persistent Cervical Cancer

Start date: July 28, 2015
Phase: Phase 2
Study type: Interventional

This study is to assess safety as defined by the frequency and severity of gastrointestinal (GI) perforation/fistula, GI-vaginal fistula and genitourinary (GU) fistula in participants treated with bevacizumab 15 milligrams per kilogram (mg/kg) in combination with paclitaxel and carboplatin, all repeated every 3 weeks, for recurrent, persistent or metastatic cervical cancer. In addition, this study will include evaluation of the overall safety profile of bevacizumab in combination with paclitaxel and carboplatin in this setting, assessment of GI perforation/fistula, GI-vaginal fistula and GU fistula events over time, and evaluation of efficacy.

NCT ID: NCT02467673 Completed - Menopausal Syndrome Clinical Trials

Nanoparticulate Versus Micronized Steroids Delivery for Transdermal Hormone Replacement Therapy

Nanoparticle
Start date: January 2012
Phase: Phase 2
Study type: Interventional

The study aims to asses the effects of micronized (MIC) and nanoparticulate (NANO) transdermal hormone therapy (THT) on blood pressure, ultra-sensitive C-reactive protein (CRP), and cardiovascular risk factors in postmenopausal women.

NCT ID: NCT02466542 Completed - Postoperative Pain Clinical Trials

Analgesic Effect of Intraoperative Esmolol in Mastectomies

Esmobreast
Start date: June 2015
Phase: Phase 4
Study type: Interventional

This study aims to compare the quality of perioperative analgesia of esmolol in patients undergoing mastectomy.

NCT ID: NCT02465502 Completed - Clinical trials for Colorectal Neoplasms

Regorafenib in Subjects With Antiangiogenic-naive and Chemotherapy-refractory Advanced Colorectal Cancer

Start date: July 21, 2015
Phase: Phase 2
Study type: Interventional

To determine the efficacy (as measured by progression-free survival [PFS] rate at 8 weeks) of regorafenib in subjects with metastatic colorectal cancer (CRC) whose disease is refractory to standard therapies and who were never exposed to antiangiogenic therapy.

NCT ID: NCT02464540 Completed - Clinical trials for Optical Properties of Laminate Veneers

Optical Properties of Light Cured Luting Agent on Laminate Veneer

Start date: March 2015
Phase: N/A
Study type: Interventional

The aim of this randomized clinical trial is to evaluate the influence of luting agent, thickness and color of laminate veneers (LVs) and color of dental substrate on the optical properties of LVs.

NCT ID: NCT02464345 Completed - Bulimia Nervosa Clinical Trials

Healthy Approach to weIght Management and Food in Eating Disorders (HAPIFED)

HAPIFED
Start date: July 7, 2015
Phase: N/A
Study type: Interventional

The investigators have developed a new integrated therapy, namely a Healthy Approach to weIght management and Food in Eating Disorders (HAPIFED). HAPIFED is an enhanced behavioral weight loss therapy integrated with CBT for the management of EDs. HAPIFED uses CBT to treat ED behaviors and body image distress, whilst simultaneously emphasize a healthy lifestyle, the role of food and physical activity in mood regulation, and revised but clinically meaningful goals for weight loss. The investigators propose a randomized controlled trial (RCT) that will compare HAPIFED to CBT-E in people with obesity and either BN or BED. The two main aims will be to reduce symptoms of ED and to improve weight management. The RCT will be conducted in Sydney and in São Paulo with a one year follow-up.

NCT ID: NCT02463552 Completed - Tooth Bleaching Clinical Trials

Naproxen on Tooth Sensitivity Caused by In-office Bleaching

Start date: May 2015
Phase: N/A
Study type: Interventional

This study aims to evaluate the effects of prior use of non-steroidal anti-inflammatory Naproxen on risk and level of tooth sensitivity caused by in-office bleaching procedures.

NCT ID: NCT02463526 Completed - Clinical trials for Shoulder Impingement Syndrome

Effects of Mulligan's Technique in Subjects With Shoulder Impingement Syndrome

Start date: April 2015
Phase: N/A
Study type: Interventional

Participants will be initially assessed for their suitability for inclusion in the study and will undergo a physical screening of the affected shoulder and cervical spine by an experienced physiotherapist. After, participants will be attended 72 hours after data recording of the baseline measures (range of motion with a goniometer, pressure pain threshold with a algometer, and peak force with a dynamometer) for four sessions per week with 24 hours of interval between sessions. At each experimental week session, each participant will receive one of the two treatment conditions (MWM or sham) and then will repeats the assessment. In the following week, there will be a crossover condition of each individual and 24 hours after the last treatment session, the examiner will do the last assessment.